VTE risk with testosterone therapy

Testosterone therapy is associated with a short-term risk for VTE in men with and without hypogonadism, US research shows. The findings, published in JAMA Internal Medicine, reinforce the need for caution and regulatory restrictions around the prescribing of testosterone. The case-control crossover study comprised almost 40,000 men with at least one inpatient or two outpatient ...

Already a member?

Login to keep reading.

© 2021 the limbic